Latest filing published 24 Aug 2026 for CLEO DIAGNOSTICS LTD, €276k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -11.1%Entry A$0.36 · Close 22 Oct 2026 A$0.32
- -36.6%Entry A$0.50 · Close at T+90 A$0.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lucinda Joan Frawley: trading record in brief
This profile gathers the share dealings of Lucinda Joan Frawley in Cleo Diagnostics Ltd. Between 3 July 2026 and 24 August 2026, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €276k). No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 24 August 2026 came the latest disclosure, an open-market purchase for €276k in Cleo Diagnostics Ltd. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lucinda Joan Frawley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations